Immediate or deferred antiretroviral therapy for central nervous system opportunistic infections? [1]

AIDS

Volumn 19, Issue 5, 2005, Pages 535-536

  Torok, M Estee ^a   Day, Jeremy N ^a   Hien, Tran J ^a   Farrar, Jeremy J ^a  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIRETROVIRUS AGENT; CORTICOSTEROID; COTRIMOXAZOLE; EFAVIRENZ; FLUCYTOSINE; LAMIVUDINE; TUBERCULOSTATIC AGENT; ZIDOVUDINE;

CENTRAL NERVOUS SYSTEM INFECTION; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DISEASE SEVERITY; FUNGAL MENINGITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INCIDENCE; LETTER; MORTALITY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; TUBERCULOUS MENINGITIS;

EID: 17144429324     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000162345.73804.e8     Document Type: Letter

References (9)

1. UNAIDS. AIDS epidemic in Asia. Available at: http://www. unaids.org/NetTools/Misc/DocInfo.aspx?LANG=en&href=http://gva-doc-owl/ WEBcontent/Documents/pub/Publications/Fact-Sheets04/FS_Asia_en.pdf. Accessed: 25 October 2004.
2. Ruxrungtham K, Brown T, Phanupak P. HIV/AIDS in Asia. Lancet 2004; 364:69-82.
3. Ruxrungtham K, Phanupak P. Update on HIV/AIDS in Thailand. J Med Assoc Thai 2001; 84 (Suppl. 1):1-17.
4. Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH. Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis 2003; 36:79-85.
5. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, et al. Dexamethasone for the treatment of tuberculous meningitis in adults and children. N Engl J Med 2004; 351:1741-1751.
6. Mayanja-Kizza H, Oishi K, Mitarai S. Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. Clin Infect Dis 1998; 26:1362-1366.
7. BHIVA. BHIVA treatment guidelines for TB/HIV infection. Available at: http://www.bhiva.org. Accessed: September 2004.
8. Centers for Disease Control and Prevention. Updated guidelines for the use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors. MMWR 2004; 53:37.
9. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. WHO/CDS/Tb 2003.313. Available at: http://www.who.int. Accessed: 25 October 2004.